Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1

Dimitri Topalis1, Tatiane C Nogueira1, Tim De Schutter1

  • 1Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.

Oncotarget
|January 30, 2016
PubMed

Insights

Cidofovir resistance in human papillomavirus-positive tumors is complex. This study reveals that altered metabolism and transporter expression contribute to cidofovir resistance in HPV(+) cancer cells.

Area of Science:

  • Oncology
  • Virology
  • Pharmacology

Background:

  • Human papillomavirus (HPV) is a key driver of cervical cancer and implicated in head and neck cancers.
  • Currently, no drugs are approved for HPV-related diseases, though cidofovir (CDV) shows antiproliferative effects.

Purpose of the Study:

  • To investigate the mechanisms of cidofovir resistance (CDVR) in HPV-positive (HPV(+)) and HPV-negative (HPV(-)) tumor cell lines.
  • To analyze alterations in CDV metabolism, drug sensitivity, and transporter expression in CDV-resistant cells.

Main Methods:

  • Cultured HPV(+) (SiHaCDV, HeLaCDV) and HPV(-) (HaCaTCDV) cell lines were developed for CDV resistance.
  • Quantified CDV metabolites and assessed sensitivity to chemotherapeutics.
  • Investigated the expression of multidrug-resistance transporters (MRP2, P-gp, BCRP).

Main Results:

  • Impaired UMP/CMPK1 activity led to altered CDV metabolism in HPV(+) cell lines (SiHaCDV, HeLaCDV), but not in HPV(-) (HaCaTCDV).
  • Specific mutations (P64T) or down-regulation of UMP/CMPK1 were observed in SiHaCDV and HeLaCDV, respectively.
  • Altered expression of multidrug-resistance transporters was noted in SiHaCDV and/or HeLaCDV, but not in HaCaTCDV.

Conclusions:

  • CDV resistance in HPV(+) tumor cells is a multifactorial process.
  • Mechanisms include impaired CDV metabolism via UMP/CMPK1 alterations and changes in transporter expression.
  • Findings provide insights into potential therapeutic strategies for HPV-related cancers.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K